hemophagocyt
lymphohistiocytosi
hlh
hyperinflammatori
syndrom
caus
uncontrol
immun
cell
genet
disord
lead
impair
lymphocyt
cytox
famili
hemophagocyt
lymphohistiocytosi
fhl
best
character
risk
factor
develop
hlh
infant
cytotox
defect
usual
asymptomat
birth
age
onset
inflammatori
symptom
vari
even
affect
indic
addit
factor
requir
mani
infect
trigger
primari
secondari
associ
fhl
manifest
infect
interpret
indic
case
trigger
hlh
even
sometim
escap
awar
detect
recent
analysi
german
hlh
registri
note
mani
fhl
patient
infect
recommend
investig
includ
blood
urin
stool
cultur
pcr
viru
ebv
cytomegaloviru
cmv
adenoviru
parvoviru
herp
simplex
viru
gastrointestin
andor
respiratori
viru
panel
case
respect
clinic
symptom
howev
sinc
patient
enrol
formal
protocol
definit
inform
whether
microbiolog
studi
perform
assum
investig
incomplet
perform
addit
search
virus
use
biomateri
store
time
hlh
diagnosi
patient
part
cohort
patient
hlh
recruit
patient
year
patient
year
document
infect
time
hlh
manifest
viral
infect
one
periungu
aureu
infect
remain
patient
access
biomateri
age
onset
year
patient
inform
consent
obtain
univers
freiburg
irb
isol
dna
rna
pellet
blood
cell
fraction
remain
ficol
separ
peripher
blood
mononuclear
cell
initi
diagnost
sampl
pcr
perform
ebv
cmv
herp
simplex
viru
hsv
human
herpesviru
hhv
respiratori
syncyti
viru
rsv
parechovirus
adenoviru
parvoviru
bk
polyomaviru
use
commerci
kit
qualiti
control
includ
pcr
torqu
teno
viru
ttv
torqu
teno
mini
viru
ttmv
two
persist
dna
virus
thought
preval
children
age
glyceraldehyd
dehydrogenas
gapdh
posit
control
assum
local
mucos
infect
could
dissemin
patient
hlh
condit
also
perform
multiplex
nucleic
acid
test
gastrointestin
pathogen
respiratori
virus
valid
methodolog
investig
patient
ebv
cmv
hlh
initi
detect
viru
could
also
found
store
biomateri
analysi
fhl
sampl
reveal
ttv
ttmv
expect
frequenc
addit
cmv
identifi
patient
notabl
remain
fhl
patient
pcr
result
remain
neg
tabl
sought
evid
fhl
manifest
absenc
infect
follow
sporad
observ
fhl
patient
alreadi
present
sign
hlh
utero
within
first
postnat
day
exposur
known
unusu
pathogen
perform
retrospect
survey
addit
systemat
literatur
search
follow
criteria
fulfil
patient
inclus
genet
diagnosi
fhl
posit
famili
histori
hlh
recurr
hlh
ii
fulfil
hlh
criteria
test
normal
hlh
criteria
less
test
iii
onset
symptom
utero
within
first
postnat
day
patient
includ
tabl
refer
supplementari
inform
refer
promin
clinic
featur
fetal
hydrop
like
result
anemia
splenomegali
tabl
frequent
hlh
criteria
splenomegali
bicytopenia
infant
supplementari
inform
tabl
genet
diagnosi
establish
patient
griscelli
syndrom
infant
die
hlh
complic
therapi
patient
aliv
hematopoiet
stem
cell
transplant
hsct
neurolog
impair
one
well
transplant
interestingli
case
infecti
trigger
document
despit
extens
investig
intrauterin
neonat
infect
remain
report
microbiolog
investig
mention
report
focus
question
whether
hlh
manifest
fhl
patient
alway
requir
infecti
trigger
report
two
patient
cohort
primari
hlh
low
incid
infect
obvious
limit
requir
discuss
first
cohort
analysi
restrict
viral
dna
rna
isol
blood
fraction
standard
viru
detect
although
could
detect
ebv
cmv
hsv
ttv
ttmv
high
copi
number
materi
could
valid
virus
test
studi
particular
virus
replic
restrict
mucos
site
also
virus
may
initi
immun
reaction
alreadi
elimin
time
blood
sampl
addit
unknown
virus
organ
virus
caus
local
system
infect
cover
panel
hand
infect
rate
similar
observ
recent
higher
rate
rang
report
earlier
studi
hlh
could
readili
differenti
also
notabl
cohort
immunosuppress
hlh
therapi
lead
secondari
emerg
pathogen
fhl
infant
present
without
appar
trigger
second
cohort
although
infect
key
initi
differenti
diagnosi
extens
investig
neonat
infect
therefor
perform
lack
standard
test
repres
limit
furthermor
commens
bacteria
virus
escap
awar
physician
may
becom
pathogen
immunodefici
patient
also
exposur
bacteria
transplacent
transmiss
pathogen
could
trigger
hlh
infant
without
caus
infecti
ill
howev
fact
singl
case
report
associ
infect
challeng
concept
hlh
manifest
fhl
patient
may
alway
requir
overt
infect
therefor
propos
besid
infect
trigger
also
consid
primari
hlh
support
observ
isol
central
nervou
system
cn
hlh
without
detect
trigger
fhl
patient
heeg
unpublish
hlh
appear
initi
primarili
steril
compart
specul
noninfecti
trigger
provok
tissu
damag
associ
danger
signal
even
development
process
fetu
requir
expans
cytotox
lymphocyt
could
suffici
initi
immun
activ
occasion
associ
diseas
onset
vaccin
support
possibl
howev
difficult
envisag
moder
local
transient
stimuli
result
system
polyclon
activ
mice
least
larg
major
hyperactiv
cell
specif
trigger
specif
cell
human
patient
remain
enigma
understand
specif
might
help
elucid
pathogenesi
hlh
uniqu
amplif
cytotox
perforin
cell
observ
hlh
may
provid
addit
biolog
viewpoint
find
consider
suggest
human
lymphocyt
cytotox
key
control
activ
also
minor
noninfecti
stimuli
way
prevent
extens
amplif
dramat
potenti
lethal
immun
respons
put
lymphocyt
cytotox
center
immun
regul
mainten
quiescenc
far
beyond
activ
viru
control
better
understand
initi
immun
reaction
hlh
role
perforin
secretori
pathway
control
therefor
highli
relev
understand
regul
human
immun
respons
ultim
also
provid
insight
relev
prophylaxi
intervent
diseas
se
scientif
collabor
ucb
relat
studi
